Importantly, impaired IFN signaling and/or unresponsiveness to IFN treatment is frequently found in different tumor types [121] including renal cell carcinoma (RCC), lung tumors, and melanoma, which was mainly determined for IFN-γ using in vitro tumor cell lines. This evidence concerns the gene IFNA1 and neoplasm.